Form 4: Core Scientific Director Jordan Levy Acquires 20,448 Shares Through Restricted Stock Unit Grant

Sentiment:

SEC Form 4 Filing


Director Jordan Levy of Core Scientific, Inc. acquired 20,448 shares of common stock through a restricted stock unit grant.

Summary

  • Jordan Levy, a director at Core Scientific, Inc., acquired 20,448 shares of common stock on January 27, 2025.
  • The acquisition was through a restricted stock unit (RSU) grant.
  • The RSUs will vest in full on January 27, 2026, provided Mr. Levy continues to serve as a non-employee director.
  • Following the transaction, Mr. Levy beneficially owns 244,387 shares of Core Scientific stock.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction of a director receiving equity compensation, which is generally positive for alignment of interests. There are no negative implications.

Positives

  • The acquisition of shares by a director demonstrates confidence in the company's future.
  • The vesting period of the RSUs aligns the director's interests with the long-term performance of the company.

Future Outlook

The vesting of the RSUs is contingent on the director's continued service, suggesting a commitment to the company's future.

Industry Context

This is a standard practice for incentivizing and aligning the interests of board members with the company's performance.

Comparison to Industry Standards

  • Restricted stock unit grants are a common form of compensation for directors in publicly traded companies.
  • The vesting period of one year is typical for such grants, aligning director interests with the company's short to medium term performance.
  • Many companies in the technology and cryptocurrency sectors use similar equity-based compensation to attract and retain board members.

Stakeholder Impact

  • The transaction increases the director's stake in the company, aligning his interests with those of shareholders.
  • The vesting period encourages the director's continued involvement and contribution to the company.

Key Dates

DateDescription
01/27/2025Date of the restricted stock unit grant and share acquisition.
01/27/2026Vesting date of the restricted stock units.
01/28/2025Date the form was signed.

Keywords

Core Scientific, Director, Jordan Levy, Restricted Stock Units, RSU, Share Acquisition, Beneficial Ownership, CORZ

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.